Vellenga E - Search Results

1

Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.

van Gosliga D, Schepers H, Rizo A, van der Kolk D, Vellenga E, Schuringa JJ. van Gosliga D, et al. Among authors: vellenga e. Exp Hematol. 2007 Oct;35(10):1538-49. doi: 10.1016/j.exphem.2007.07.001. Exp Hematol. 2007. PMID: 17889721 Free article.

2

HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun.

Schepers H, Geugien M, van der Toorn M, Bryantsev AL, Kampinga HH, Eggen BJ, Vellenga E. Schepers H, et al. Among authors: vellenga e. Exp Hematol. 2005 Jun;33(6):660-70. doi: 10.1016/j.exphem.2005.03.009. Exp Hematol. 2005. PMID: 15911090 Free article.

3

STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.

Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. Blood. 2006 Jun 1;107(11):4326-33. doi: 10.1182/blood-2005-11-4608. Epub 2006 Feb 2. Blood. 2006. PMID: 16455947 Free article.

4

Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells.

Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG, Vellenga E. Peeters SD, et al. Among authors: vellenga e. Exp Hematol. 2006 May;34(5):622-30. doi: 10.1016/j.exphem.2006.01.020. Exp Hematol. 2006. PMID: 16647568 Free article.

5

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Rizo A, Vellenga E, de Haan G, Schuringa JJ. Rizo A, et al. Among authors: vellenga e. Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R210-9. doi: 10.1093/hmg/ddl175. Hum Mol Genet. 2006. PMID: 16987886 Review.

6

Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.

Schepers H, Wierenga AT, van Gosliga D, Eggen BJ, Vellenga E, Schuringa JJ. Schepers H, et al. Among authors: vellenga e. Blood. 2007 Aug 15;110(4):1317-25. doi: 10.1182/blood-2006-10-052175. Epub 2007 May 2. Blood. 2007. PMID: 17475913 Free article.

7

Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires rac-mediated interaction with stromal cells.

Rozenveld-Geugien M, Baas IO, van Gosliga D, Vellenga E, Schuringa JJ. Rozenveld-Geugien M, et al. Among authors: vellenga e. Exp Hematol. 2007 May;35(5):782-92. doi: 10.1016/j.exphem.2007.02.006. Exp Hematol. 2007. PMID: 17577927 Free article.

8

STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.

Schepers H, van Gosliga D, Wierenga AT, Eggen BJ, Schuringa JJ, Vellenga E. Schepers H, et al. Among authors: vellenga e. Blood. 2007 Oct 15;110(8):2880-8. doi: 10.1182/blood-2006-08-039073. Epub 2007 Jul 13. Blood. 2007. PMID: 17630355 Free article.

9

Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1.

Rizo A, Dontje B, Vellenga E, de Haan G, Schuringa JJ. Rizo A, et al. Among authors: vellenga e. Blood. 2008 Mar 1;111(5):2621-30. doi: 10.1182/blood-2007-08-106666. Epub 2007 Dec 21. Blood. 2008. PMID: 18156489 Free article.

10

Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.

Fatrai S, Schepers H, Tadema H, Vellenga E, Daenen SM, Schuringa JJ. Fatrai S, et al. Among authors: vellenga e. Exp Hematol. 2008 Oct;36(10):1254-65. doi: 10.1016/j.exphem.2008.04.015. Epub 2008 Jul 21. Exp Hematol. 2008. PMID: 18640764 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters